Drug Changes
Here you will find a listing of the drugs that have been changed on our drug list (formulary) for the plan year you select.
To request Medicare Part D prescription drug coverage determinations (including tiering or formulary exception requests) please use the following form:
Denavir Cream 1 % External
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Penciclovir Cream 1 % External |
Tier 2 |
ST |
Topical Anti-infectives |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Tazorac Gel 0.05 % External
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Tazarotene Gel 0.05 % External |
Tier 4 |
|
Acne and Rosacea Agents |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Tazorac Gel 0.1 % External
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Tazarotene Gel 0.1 % External |
Tier 4 |
|
Acne and Rosacea Agents |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Esbriet Capsule 267 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Pirfenidone Capsule 267 MG Oral |
Tier 5 |
PA, QL |
Pulmonary Fibrosis Agents |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Hetlioz Capsule 20 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Tasimelteon Capsule 20 MG Oral |
Tier 5 |
PA, QL |
Sleep Promoting Agents |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Latuda Tablet 120 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Lurasidone HCl Tablet 120 MG Oral |
Tier 5 |
|
2nd Generation/Atypical |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Latuda Tablet 20 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Lurasidone HCl Tablet 20 MG Oral |
Tier 5 |
QL |
2nd Generation/Atypical |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Latuda Tablet 40 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Lurasidone HCl Tablet 40 MG Oral |
Tier 5 |
QL |
2nd Generation/Atypical |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Latuda Tablet 60 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Lurasidone HCl Tablet 60 MG Oral |
Tier 5 |
QL |
2nd Generation/Atypical |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Latuda Tablet 80 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Lurasidone HCl Tablet 80 MG Oral |
Tier 5 |
|
2nd Generation/Atypical |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Cardizem LA Tablet Extended Release 24 Hour 120 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
dilTIAZem HCl ER Tablet Extended Release 24 Hour 120 MG Oral |
Tier 2 |
|
Calcium Channel Blocking Agents, Nondihydropyridines |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Kyzatrex Capsule 100 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Testosterone Cypionate Solution 100 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Cypionate Solution 200 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Enanthate Solution 200 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Gel 10 MG/ACT (2%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Gel 12.5 MG/ACT (1%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Gel 25 MG/2.5GM (1%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Gel 50 MG/5GM (1%) Transdermal |
Tier 2 |
QL |
Androgens |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Kyzatrex Capsule 150 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Testosterone Cypionate Solution 100 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Cypionate Solution 200 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Enanthate Solution 200 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Gel 10 MG/ACT (2%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Gel 12.5 MG/ACT (1%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Gel 25 MG/2.5GM (1%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Gel 50 MG/5GM (1%) Transdermal |
Tier 2 |
QL |
Androgens |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Kyzatrex Capsule 200 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Testosterone Gel 12.5 MG/ACT (1%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Gel 25 MG/2.5GM (1%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Gel 50 MG/5GM (1%) Transdermal |
Tier 2 |
QL |
Androgens |
Testosterone Cypionate Solution 100 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Cypionate Solution 200 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Enanthate Solution 200 MG/ML Intramuscular |
Tier 2 |
|
Androgens |
Testosterone Gel 10 MG/ACT (2%) Transdermal |
Tier 2 |
QL |
Androgens |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Matzim LA Tablet Extended Release 24 Hour 180 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Matzim LA Tablet Extended Release 24 Hour 180 MG Oral |
Tier 2 |
|
Calcium Channel Blocking Agents, Nondihydropyridines |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Matzim LA Tablet Extended Release 24 Hour 240 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Matzim LA Tablet Extended Release 24 Hour 240 MG Oral |
Tier 2 |
|
Calcium Channel Blocking Agents, Nondihydropyridines |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Matzim LA Tablet Extended Release 24 Hour 300 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Matzim LA Tablet Extended Release 24 Hour 300 MG Oral |
Tier 2 |
|
Calcium Channel Blocking Agents, Nondihydropyridines |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Matzim LA Tablet Extended Release 24 Hour 360 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Matzim LA Tablet Extended Release 24 Hour 360 MG Oral |
Tier 2 |
|
Calcium Channel Blocking Agents, Nondihydropyridines |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Matzim LA Tablet Extended Release 24 Hour 420 MG Oral
Type of Change:
Drug removed - Discontinued from marketplace
Reason Changed:
Drug discontinued from marketplace
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Matzim LA Tablet Extended Release 24 Hour 420 MG Oral |
Tier 2 |
|
Calcium Channel Blocking Agents, Nondihydropyridines |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Naftin Gel 2 % External
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Naftifine HCl Gel 2 % External |
Tier 4 |
|
Antifungals |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Noxafil Suspension 40 MG/ML Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Posaconazole Suspension 40 MG/ML Oral |
Tier 5 |
PA |
Antifungals |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Celontin Capsule 300 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Methsuximide Capsule 300 MG Oral |
Tier 4 |
|
Calcium Channel Modifying Agents |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Iressa Tablet 250 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Gefitinib Tablet 250 MG Oral |
Tier 5 |
PA, QL |
Molecular Target Inhibitors |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Orfadin Capsule 20 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Nitisinone Capsule 20 MG Oral |
Tier 5 |
PA |
Genetic or Enzyme or Protein Disorder: Replacement, Modifiers, Treatment |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Prezista Tablet 600 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Darunavir Tablet 600 MG Oral |
Tier 5 |
|
Anti-HIV Agents, Protease Inhibitors (PI) |
* Please reference your Evidence of Coverage for applicable cost-sharing. |
Prezista Tablet 800 MG Oral
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Alternative Drugs
Drug |
Tier* |
Drug Restrictions |
Therapy Class |
Darunavir Tablet 800 MG Oral |
Tier 5 |
|
Anti-HIV Agents, Protease Inhibitors (PI) |
* Please reference your Evidence of Coverage for applicable cost-sharing. |